 |
 |

The Treatment of Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome
Catherine Butkus Small, MD;
Carol A. Harris, MD;
Gerald H. Friedland, MD;
Robert S. Klein, MD
Arch Intern Med. 1985;145(5):837-840.
Abstract
 |  |
Forty-four episodes of Pneumocystis carinii pneumonia (PCP) occurred in 36 of 70 patients with the acquired immunodeficiency syndrome. Thirty-four patients with 40 episodes of PCP were treated with trimethoprim-sulfamethoxazole. Therapy was successful in 18 episodes (45%), but was unsuccessful in 15 episodes (37.5%). In the latter cases, two patients died within 72 hours; 13, of whom nine died, had therapy changed to pentamidine. In seven additional episodes (17.5%), trimethoprim-sulfamethoxazole was changed to pentamidine due to adverse reactions; all patients survived. Seven patients (26% of survivors) developed recurrent PCP. Twenty-two patients (65%) developed adverse reactions to trimethoprim-sulfamethoxazole, including leukopenia (20), hepatotoxicity (12), fever (eight), rash (six), and immediate reactions (two). Reactions were most common during the second week of therapy. Patients with the acquired immunodeficiency syndrome who have PCP have a high trimethoprim-sulfamethoxazole failure rate, due either to adverse reactions or unresponsive infection. Late recurrence is common.
(Arch Intern Med 1985;145:837-840)
Author Affiliations
From the Division of Infectious Diseases, Department of Medicine, Montefiore Medical Center and North Central Bronx Hospital (Drs Small, Harris, Friedland, and Klein), and the Department of Medicine, Albert Einstein College of Medicine (Drs Small, Harris, Friedland, and Klein), Bronx, NY. Dr Small is now with the Westchester County Medical Center, Valhalla, NY.
Footnotes
Accepted for publication Sept 21, 1984.
Read in part before the 23rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Las Vegas, Oct 25, 1983.
Reprint requests to Division of Infectious Diseases, Montefiore Medical Center, 111 E 210th St, Bronx, NY 10467 (Dr Klein).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Increased Adverse Drug Reactions to Antimicrobials and Anticonvulsants in Patients with HIV Infection
Lin et al.
The Annals of Pharmacotherapy 2006;40:1594-1601.
ABSTRACT
| FULL TEXT
Management of Adverse Reactions to Trimethoprim-Sulfamethoxazole in Human Immunodeficiency Virus--Infected Patients
Jung and Paauw
Arch Intern Med 1994;154:2402-2406.
ABSTRACT
Adverse Cutaneous Reactions to Trimethoprim-Sulfamethoxazole in Patients With the Acquired Immunodeficiency Syndrome and Pneumocystis carinii Pneumonia
Roudier et al.
Arch Dermatol 1994;130:1383-1386.
ABSTRACT
Aerosolized Pentamidine: Effect on Diagnosis and Presentation of Pneumocystis carinii Pneumonia
Jules-Elysee et al.
ANN INTERN MED 1990;112:750-757.
ABSTRACT
Pneumocystis carinii Pneumonia in Human Immunodeficiency Virus-Infected Patients
Glatt and Chirgwin
Arch Intern Med 1990;150:271-279.
ABSTRACT
Serum Triiodothyronine Values: Prognostic Indicators of Acute Mortality due to Pneumocystis carinii Pneumonia Associated With the Acquired Immunodeficiency Syndrome
Fried et al.
Arch Intern Med 1990;150:406-409.
ABSTRACT
Trimethoprim-Sulfamethoxazole Compared with Pentamidine for Treatment of Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome: A Prospective, Noncrossover Study
Sattler et al.
ANN INTERN MED 1988;109:280-287.
ABSTRACT
Empirical Diagnosis of Pneumocystis carinii Pneumonia-Reply
Chaisson and Hopewell
JAMA 1988;259:2850-2850.
ABSTRACT
Cutaneous Reactions to Trimethoprim-Sulfamethoxazole in African Patients with the Acquired Immunodeficiency Syndrome
COLEBUNDERS et al.
ANN INTERN MED 1987;107:599-600.
ABSTRACT
Early Predictors of In-Hospital Mortality for Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome
Kales et al.
Arch Intern Med 1987;147:1413-1417.
ABSTRACT
Treatment of Patients With Acquired Immunodeficiency Syndrome and Associated Manifestations
Kaplan et al.
JAMA 1987;257:1367-1374.
ABSTRACT
Intravenous Drug Abusers and HIV Infections: A Consequence of Their Actions
Ginzburg
J Law Med Ethics 1986;14:268-272.
|